SAN DIEGO (AP) — Telesis Bio, Inc. TBIO) on Wednesday reported a loss of $12.6 million in its second quarter. On a per-share basis, the San Diego-based company said it had a loss of $7.62.

The global 3D bio-printing market is poised for significant expansion, with projections indicating a rise from an ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 70.45% ...

Nuvation Bio Inc (NUVB) stock saw a decline, ending the day at $2.9 which represents a decrease of $-0.17 or -5.54% from the prior close of $3.07. The stock opened at $3.05 and touched a low of $2.83 ...

Fourth-quarter revenue of $0.73 million, up 64% year-over-year –- Full-year revenue of $3.11 million, up 148% year-over-year –- As of June 30, ...

PHILADELPHIA, PA — Passage Bio, Inc. has unveiled promising interim data from its ongoing global Phase 1/2 upliFT-D clinical ...

ALS, MS, post-traumatic brain injury? This biotech company has a target choice to make for an upcoming clinical trial — and ...

Upstream Bio, Inc. has filed for an Initial Public Offering (IPO) and seeks to list its common stock on the Nasdaq Global Market under the symbol 'UPB'. Leading financial institutions J.P. Morgan, TD ...

Analyst Jason McCarthy from Maxim Group maintained a Buy rating on Inmune Bio (INMB – Research Report) and keeping the price target at ...

Because this plan is a short plan based on a test of resistance it is referred to as a Short Resistance Plan. Check the time stamp on this data. Updated AI-Generated Signals for Bio-rad Laboratories ...